Duke Street (DS Spring)/DCC Vital (UK) & Kent Pharma UK
Transaction details
The proposed acquisition by Duke Street, via DS Spring Bidco Limited of sole control of each of DCC Vital (UK) Limited and Kent Pharma UK Limited has been cleared by the Competition and Consumer Protection Commission.
Case details
- Notification date:24 June 2019
- Publication date:24 June 2019
- Economic sector:Wholesale & retail trade - G
- Economic sub-sector:Wholesale trade - G.46
- Outcome:Cleared
Documents
M.19.017 Merger AnnouncementPDF | 435 KBM.19.017 Merger Announcement PDF | 435 KB - Opens in new window
M.19.017 DeterminationPDF | 238 KBM.19.017 Determination PDF | 238 KB - Opens in new window
Timetable
Parties Involved
Duke Street LLP
The acquirer, DS Spring Bidco Limited, is a portfolio company ultimately controlled by Duke Street LLP. Duke Street LLP is a private equity firm specialising in investing in mature, mid-market western European businesses. Duke Street LLP focuses on four primary sector markets, Consumer, Healthcare, Industrials and and Engineering, and Services.
Kent Pharma UK Limited
Kent Pharma UK Limited is involved in the manufacture, supply and service of generic medicines across hospitals and primary and secondary care sectors. It is currently owned and controlled by Fannin (UK) Limited, and is ultimately owned and controlled by DCC plc.
DCC Vital (UK) Limited
DCC Vital (UK) Limited sells and distributes a broad range of own and third party pharmaceutical products to healthcare providers across the UK and Ireland. DCC Vital (UK) Limited is owned and controlled by DCC Vital Ireland Limited. All of these entities are ultimately owned and controlled by DCC plc.
Contacts
Donnacha Hennessy donnachahennessy@ccpc.ie
